{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:02:29Z","timestamp":1786982549341,"version":"build-2736575974"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T00:00:00Z","timestamp":1586908800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T00:00:00Z","timestamp":1586908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Med. Toxicol."],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s13181-020-00773-9","type":"journal-article","created":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T18:02:51Z","timestamp":1586973771000},"page":"321-328","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Lithium Toxicity from the Addition of an ACE Inhibitor with an Unexpected Type I Brugada Pattern ECG: Case Files of the Medical Toxicology Fellowship at the University of California, San Diego"],"prefix":"10.1007","volume":"16","author":[{"given":"Aaron","family":"Schneir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford P.","family":"Masom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,15]]},"reference":[{"key":"773_CR1","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s40262-016-0370-y","volume":"55","author":"PR Finley","year":"2016","unstructured":"Finley PR. Drug interactions with lithium: an update. Clin Pharmacokinet. 2016;55:925\u201341.","journal-title":"Clin Pharmacokinet"},{"key":"773_CR2","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/00004714-199602000-00011","volume":"16","author":"PR Finley","year":"1996","unstructured":"Finley PR, O\u2019Brien JG, Coleman RW. Lithium and angiotensin-converting enzyme inhibitors: evaluation of a potential interaction. J Clin Psychopharmacol. 1996;16:68\u201371.","journal-title":"J Clin Psychopharmacol"},{"key":"773_CR3","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1532-5415.2004.52221.x","volume":"52","author":"DN Juurlink","year":"2004","unstructured":"Juurlink DN, Mamdani MM, Kopp A, Rochon PA, Shulman KI, Redelmeier DA. Drug-induced lithium toxicity in the elderly: a population-based study. J Am Geriatr Soc. 2004;52:794\u20138.","journal-title":"J Am Geriatr Soc"},{"key":"773_CR4","first-page":"946","volume":"24","author":"CM Baldwin","year":"1990","unstructured":"Baldwin CM, Safferman AZ. A case of lisinopril-induced lithium toxicity. Ann Pharmacother. 1990;24:946\u20137.","journal-title":"Ann Pharmacother"},{"key":"773_CR5","first-page":"101","volume":"25","author":"JH Griffin","year":"1991","unstructured":"Griffin JH, Hahn SM. Lisinopril-induced lithium toxicity. Ann Pharmacother. 1991;25:101.","journal-title":"Ann Pharmacother"},{"key":"773_CR6","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/0002-9343(92)90693-6","volume":"93","author":"FJ Correa","year":"1992","unstructured":"Correa FJ, Eiser AR. Angiotensin-converting enzyme inhibitors and lithium toxicity. Am J Med. 1992;93:108\u20139.","journal-title":"Am J Med"},{"key":"773_CR7","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0033-3182(93)71851-4","volume":"34","author":"M Teitelbaum","year":"1993","unstructured":"Teitelbaum M. A significant increase in lithium levels after concomitant ACE inhibitor administration. Psychosomatics. 1993;34:450\u20133.","journal-title":"Psychosomatics."},{"key":"773_CR8","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/S0140-6736(86)91598-9","volume":"327","author":"PH Douste-Blazy","year":"1996","unstructured":"Douste-Blazy PH, Rostin M, Livarek B, Tordjman E, Montastruc JL, Galinier F. Angiotensin converting enzyme inhibitors and lithium treatment. Lancet. 1996;327:1448.","journal-title":"Lancet."},{"key":"773_CR9","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0002-9343(88)80054-8","volume":"85","author":"G Simon","year":"1998","unstructured":"Simon G. Combination angiotensin converting enzyme inhibitor\/lithium therapy contraindicated in renal disease. Am J Med. 1998;85:893\u20134.","journal-title":"Am J Med"},{"key":"773_CR10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00004850-200503000-00010","volume":"20","author":"JM Meyer","year":"2005","unstructured":"Meyer JM, Dollarhide A, Tuan I. Lithium toxicity after switch from fosinopril to lisinopril. Int Clin Psychopharmacol. 2005;20:115\u20138.","journal-title":"Int Clin Psychopharmacol"},{"key":"773_CR11","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1751-7176.2009.00181.x","volume":"11","author":"J Handler","year":"2009","unstructured":"Handler J. Lithium and antihypertensive medication: a potentially dangerous interaction. J Clin Hypertens. 2009;11:738\u201342.","journal-title":"J Clin Hypertens"},{"key":"773_CR12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/HJH.0000000000000758","volume":"34","author":"V Bisogni","year":"2016","unstructured":"Bisogni V, Rossitto G, Reghin F, Padrini R, Rossi GP. Antihypertensive therapy in patients on chronic lithium treatment for bipolar disorders. J Hypertens. 2016;34:20\u20138.","journal-title":"J Hypertens"},{"key":"773_CR13","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s40261-019-00768-7","volume":"39","author":"L Hommers","year":"2019","unstructured":"Hommers L, Fischer M, Reif-Leonhard C, Pfuhlmann B, Deckert J, Unterecker S. The combination of lithium and ACE inhibitors: hazardous, critical, possible? Clin Drug Investig. 2019;39:485\u20139.","journal-title":"Clin Drug Investig"},{"key":"773_CR14","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0002-9343(89)90399-9","volume":"86","author":"GJ Navis","year":"1989","unstructured":"Navis GJ, Jong PE, Zeeuw D. Volume homeostasis, angiotensin converting enzyme inhibition, and lithium therapy. Am J Med. 1989;86:621.","journal-title":"Am J Med"},{"key":"773_CR15","first-page":"398","volume":"11","author":"K DasGupta","year":"1992","unstructured":"DasGupta K, Jefferson JW, Kobak KA, Greist JH. The effect of enalapril on serum lithium levels in healthy men. J Clin Psychiatry. 1992;11:398\u2013400.","journal-title":"J Clin Psychiatry"},{"key":"773_CR16","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/archinte.160.5.685","volume":"160","author":"GL Bakris","year":"2000","unstructured":"Bakris GL, Weir MR. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine. Is this a cause for concern? Arch Intern Med. 2000;160:685\u201393.","journal-title":"Arch Intern Med"},{"key":"773_CR17","doi-asserted-by":"crossref","first-page":"S216","DOI":"10.1097\/CCM.0b013e318168e375","volume":"36","author":"P Neesh","year":"2008","unstructured":"Neesh P, Nadim MK. An overview of drug-induced acute kidney injury. Crit Care Med. 2008;36:S216\u201323.","journal-title":"Crit Care Med"},{"key":"773_CR18","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1161\/hc4101.096153","volume":"16","author":"AC Schoolwerth","year":"2001","unstructured":"Schoolwerth AC, Sica DA, Ballermann BJ, Wilcox CS. Renal considerations in angiotensin converting enzyme inhibitor therapy: a statement for healthcare professionals from the council on the kidney in cardiovascular disease and the council for high blood pressure research of the American heart association. Circulation. 2001;16:1985\u201391.","journal-title":"Circulation."},{"key":"773_CR19","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/sj.jhh.1001571","volume":"17","author":"C Stirling","year":"2003","unstructured":"Stirling C, Houston J, Robertson S, Boyle J, Allan A, Norrie J, et al. Diarrhoea, vomiting and ACE inhibitors: an important cause of acute renal failure. J Hum Hypertens. 2003;17:419\u201323.","journal-title":"J Hum Hypertens"},{"key":"773_CR20","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0272-6386(95)90632-0","volume":"25","author":"K Lehmann","year":"1995","unstructured":"Lehmann K, Ritz E. Angiotensin-converting enzyme inhibitors may cause renal dysfunction in patients on long-term lithium treatment. Am J Kidney Dis. 1995;25:82\u20137.","journal-title":"Am J Kidney Dis"},{"key":"773_CR21","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s12882-018-1101-4","volume":"19","author":"J Davis","year":"2018","unstructured":"Davis J, Desmond M, Berk M. Lithium and nephrotoxicity: a literature review of approaches to clinical management and risk stratification. BMC Nephrol. 2018;19:305.","journal-title":"BMC Nephrol"},{"key":"773_CR22","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2215\/CJN.10021014","volume":"10","author":"BS Decker","year":"2015","unstructured":"Decker BS, Goldfarm DS, Dargan PI, Friesen M, Gosselin S, Hoffman RS, et al. Extracorporeal treatment for lithium poisoning: systematic review and recommendations from the EXTRIP workgroup. Clin J Am Soc Nephrol. 2015;10:875\u201387.","journal-title":"Clin J Am Soc Nephrol"},{"key":"773_CR23","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/0735-6757(95)90202-3","volume":"13","author":"SM Watling","year":"1995","unstructured":"Watling SM, Gherke JC, Gehrke CW, Zumwalt R, Pribble J. In vitro binding of lithium using the cation exchange resin sodium polystyrene sulfonate. Am J Emerg Med. 1995;13:294\u20136.","journal-title":"Am J Emerg Med"},{"key":"773_CR24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0735-6757(96)90010-8","volume":"14","author":"JC Gehrke","year":"1996","unstructured":"Gehrke JC, Watling SM, Gehrke CW, Zumwalt R. In-vivo binding of lithium using the cation exchange resin sodium polystyrene sulfonate. Am J Emerg Med. 1996;14:37\u20138.","journal-title":"Am J Emerg Med"},{"key":"773_CR25","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1600-0773.1989.tb01194.x","volume":"65","author":"JG Linakis","year":"1989","unstructured":"Linakis JG, Lacouture PG, Eisenberg MS, Maher TJ, Lewander WJ, Driscoll JL, et al. Administration of activated charcoal or sodium polystyrene sulfonate (kayexalate\u2122) as gastric decontamination for lithium intoxication: an animal model. Pharmacol Toxicol. 1989;65:387\u20139.","journal-title":"Pharmacol Toxicol"},{"key":"773_CR26","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/S0196-0644(05)81892-X","volume":"21","author":"C Tomasezewski","year":"1992","unstructured":"Tomasezewski C, Musso C, Pearson JR, Kulig K, Marx JA. Lithium absorption prevented by sodium polystyrene sulfonate in volunteers. Ann Emerg Med. 1992;21:1308\u201311.","journal-title":"Ann Emerg Med"},{"key":"773_CR27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3109\/15563659809028026","volume":"36","author":"JG Linakis","year":"1998","unstructured":"Linakis JG, Savitt DL, Wu T, Lockhart GR, Lacouture PG. Use of sodium polystyrene sulfonate for reduction of plasma lithium concentrations after chronic lithium dosing in mice. J Toxicol Clin Toxicol. 1998;36:309\u201313.","journal-title":"J Toxicol Clin Toxicol"},{"key":"773_CR28","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1553-2712.1997.tb03736.x","volume":"4","author":"JG Linakis","year":"1997","unstructured":"Linakis JG, Hull KM, Lacouture PG, Lockart GR, Lewander WJ, Maher TJ. Enhancement of lithium elimination by multiple-dose sodium polystyrene sulfonate. Acad Emerg Med. 1997;4:175\u20138.","journal-title":"Acad Emerg Med"},{"key":"773_CR29","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1600-0773.1992.tb00422.x","volume":"70","author":"JG Linakis","year":"1992","unstructured":"Linakis JG, Eisenberg MS, Lacouture PG, Maher TJ, Lewander WJ, Driscoll JL, et al. Multiple-dose sodium polystyrene sulfonate in lithium intoxication: an animal model. Pharmacol Toxicol. 1992;70:38\u201340.","journal-title":"Pharmacol Toxicol."},{"key":"773_CR30","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3109\/15563650903344785","volume":"48","author":"M Ghannoum","year":"2010","unstructured":"Ghannoum M, LaVergne V, Yue CS, Ayoub P, Perreault MM, Roy L. Successful treatment of lithium toxicity with sodium polystyrene sulfonate: a retrospective cohort study. Clin Toxicol. 2010;48:34.","journal-title":"Clin Toxicol"},{"key":"773_CR31","doi-asserted-by":"crossref","first-page":"264.e9","DOI":"10.1016\/j.amjmed.2012.08.016","volume":"126","author":"Z Harel","year":"2013","unstructured":"Harel Z, Harel S, Shah PS, Wald R, Perl J, Bell CM. Gastrointestinal adverse events with sodium polystyrene sulfonate (kayexalate) use: a systematic review. Am J Med. 2013;126:264.e9\u201324.","journal-title":"Am J Med"},{"key":"773_CR32","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/clc.22822","volume":"40","author":"N Mehta","year":"2017","unstructured":"Mehta N, Vannozzi R. Lithium-induced electrocardiographic changes: a complete review. Clin Cardiol. 2017;40:1363\u20137.","journal-title":"Clin Cardiol"},{"key":"773_CR33","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.recesp.2016.01.001","volume":"69","author":"SG Priori","year":"2016","unstructured":"Priori SG, Blomstr\u00f6m-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden death. Revista Espa\u00f1ola Cardiolog\u00eda. 2016;69:176.","journal-title":"Revista Espa\u00f1ola Cardiolog\u00eda"},{"key":"773_CR34","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/01.CIR.0000152479.54298.51","volume":"111","author":"C Anzelevitch","year":"2005","unstructured":"Anzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, et al. Brugada syndrome: report of the second consensus conference. Circulation. 2005;111:659\u201370.","journal-title":"Circulation."},{"key":"773_CR35","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jelectrocard.2012.06.004","volume":"45","author":"AB De Luna","year":"2012","unstructured":"De Luna AB, Brugada J, Baranchuk A, Borggrefe M, Breithardt G, Goldwasser D, et al. Current electrocardiographic criteria for diagnosis of Brugada pattern: a consensus report. J Electrocardiol. 2012;45:433\u201342.","journal-title":"J Electrocardiol"},{"key":"773_CR36","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.hrthm.2013.05.014","volume":"10","author":"SG Priori","year":"2013","unstructured":"Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C, et al. HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Heart Rhythm. 2013;10:1932\u201363.","journal-title":"Heart Rhythm"},{"key":"773_CR37","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1161\/CIRCULATIONAHA.105.548487","volume":"112","author":"D Darbar","year":"2005","unstructured":"Darbar D, Yang T, Churchwell K, Wilde AAM, Roden DM. Unmasking of brugada syndrome by lithium. Circulation. 2005;112:1527\u201331.","journal-title":"Circulation."},{"key":"773_CR38","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.lpm.2006.11.028","volume":"36","author":"R Sandras","year":"2007","unstructured":"Sandras R, Lesaffre F, Lacotte J, Nazeyrollas P. Un syndrome de brugada major\u00e9 par un traitement au lithium. La Presse M\u00e9dical. 2007;36:612\u20134.","journal-title":"La Presse M\u00e9dical"},{"issue":"1","key":"773_CR39","doi-asserted-by":"crossref","first-page":"113.e.1","DOI":"10.1016\/j.ajem.2007.06.028","volume":"26","author":"MJ Pirotte","year":"2008","unstructured":"Pirotte MJ, Mueller JG, Poprawski T. A case report of Brugada-type electrocardiographic changes in a patient taking lithium. Am J Emerg Med. 2008;26(1):113.e.1\u20133.","journal-title":"Am J Emerg Med"},{"key":"773_CR40","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1097\/SMJ.0b013e3181bfae69","volume":"102","author":"PA Chandra","year":"2009","unstructured":"Chandra PA, Chandra AB. Brugada syndrome unmasked by lithium. South Med J. 2009;102:1263\u20135.","journal-title":"South Med J"},{"key":"773_CR41","first-page":"e418","volume":"122","author":"D Wright","year":"2010","unstructured":"Wright D, Salehian O. Brugada-type electrocardiographic chances induced by long-term lithium use. Circulation. 2010;122:e418\u20139.","journal-title":"Circulation."},{"key":"773_CR42","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/ccr3.136","volume":"3","author":"RR Crawford","year":"2014","unstructured":"Crawford RR, Higdon AN, Casey DB, Good DE, Mungrue IN. Multiple lithium-dependent Brugada syndrome unmasking events in a bipolar patient. Clin Case Rep. 2014;3:14\u20138.","journal-title":"Clin Case Rep"},{"issue":"12 Supplement","key":"773_CR43","doi-asserted-by":"crossref","first-page":"A645","DOI":"10.1016\/S0735-1097(14)60645-8","volume":"63","author":"A Parashar","year":"2014","unstructured":"Parashar A, Sheikh F, Swank G. Lithium induced Brugada pattern. J Am Cardiol. 2014;63(12 Supplement):A645.","journal-title":"J Am Cardiol"},{"key":"773_CR44","first-page":"235","volume":"43","author":"DI Gentille-Lorente","year":"2015","unstructured":"Gentille-Lorente DI, Lechuga-Dur\u00e1nt I. Brugada type 1 pattern and lithium therapy. Actas Esp Psiquiatr. 2015;43:235\u20138.","journal-title":"Actas Esp Psiquiatr"},{"key":"773_CR45","first-page":"650","volume":"45","author":"S Asil","year":"2017","unstructured":"Asil S, Canpolat U, Kaya EB, Aytemir K, Kabak\u00e7i G. Case series of three different scenarios with drug-induced Brugada patterns: fact or fiction? Turk Kardiyol Dern Ars. 2017;45:650\u20134.","journal-title":"Turk Kardiyol Dern Ars"},{"key":"773_CR46","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1176\/appi.ajp.2007.07020226","volume":"164","author":"C Laske","year":"2007","unstructured":"Laske C, Soekadar SR, Laszlo R, Plewnia C. Brugada syndrome in a patient treated with lithium. Am J Psychiatry. 2007;164:1440\u20131.","journal-title":"Am J Psychiatry"},{"key":"773_CR47","first-page":"e408","volume":"113","author":"D Darbar","year":"2006","unstructured":"Darbar D, Yang T, Roden DM, Churchwell K, Wilde AA. Letter regarding article by Darbar et al, \u201cunmasking of brugada syndrome by lithium\u201d-response. Circulation. 2006;113:e408.","journal-title":"Circulation."},{"key":"773_CR48","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1542-474X.2012.00525.x","volume":"17","author":"A Baranchuk","year":"2012","unstructured":"Baranchuk A, Nguyen T, Ryu MH, Femen\u00eda F, Zareba W, Wilde AA, et al. Brugada phenocopy: new terminology and proposed classification. Ann Noninvasive Electrocardiol. 2012;17:299\u2013314.","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"773_CR49","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/europace\/euq034","volume":"12","author":"A Tamene","year":"2010","unstructured":"Tamene A, Sattiraju S, Wang K, Benditt DG. Brugada-like electrocardiography pattern induced by severe hyponatremia. Europace. 2010;12:905\u20137.","journal-title":"Europace."},{"key":"773_CR50","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000327089","volume":"118","author":"PA Alvarez","year":"2011","unstructured":"Alvarez PA, Blanco MV, Lerman J. Brugada type 1 electrocardiographic pattern induced by severe hyponatremia. Cardiology. 2011;118:97\u2013100.","journal-title":"Cardiology."},{"key":"773_CR51","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jsha.2016.02.003","volume":"28","author":"Y Agrawal","year":"2016","unstructured":"Agrawal Y, Aggarwal S, Kalavakunta JK, Gupta V. All that looks like \u201cBrugada\u201d is not \u201cBrugada\u201d: case series of Brugada phenocopy caused by hyponatremia. J Saudi Heart Assoc. 2016;28:274\u20137.","journal-title":"J Saudi Heart Assoc"},{"key":"773_CR52","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2147\/IMCRJ.S200201","volume":"12","author":"K Ramsaroop","year":"2019","unstructured":"Ramsaroop K, Seecheran R, Seecheran V, Persad S, Giddings S, Mohammed B, et al. Suspected hyponatremia-induced brugada phenocopy. Int Med Case Rep J. 2019;12:61\u20135.","journal-title":"Int Med Case Rep J"},{"key":"773_CR53","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/BF00373920","volume":"430","author":"XM Xie","year":"1995","unstructured":"Xie XM, Lancaster B, Peakman T, Garthwaite J. Interaction of the antiepileptic drug lamotrigine with recombinant rat brain type IIA N+ channels and with native Na+ channels in rat hippocampal neurones. Pflugers Arch. 1995;430:437\u201346.","journal-title":"Pflugers Arch"},{"key":"773_CR54","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/WNF.0b013e3181e8ac66","volume":"33","author":"WJ Strimel","year":"2010","unstructured":"Strimel WJ, Woodruff A, Cheung P, Kirmani BF, Huang S, Shoel K. Brugada-like electrocardiographic pattern induced by lamotrigine toxicity. Clin Neuropharmacol. 2010;33:265\u20137.","journal-title":"Clin Neuropharmacol"},{"key":"773_CR55","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.repc.2013.01.009","volume":"32","author":"R Rodrigues","year":"2013","unstructured":"Rodrigues R, Amador P, Rassi L, Seixo F, Parreira L, Fonseca N, et al. Padr\u00e3o de Brugada em doente medicada com lamotrigina. Rev Port Cardiol. 2013;32:807\u201310.","journal-title":"Rev Port Cardiol"},{"key":"773_CR56","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.hrcr.2016.11.006","volume":"3","author":"KM Leong","year":"2017","unstructured":"Leong KM, Seligman H, Varnava AM. Proarrhythmogenic effects of lamotrigine during ajmaline testing for Brugada syndrome. HeartRhythm Case Rep. 2017;3:167\u201371.","journal-title":"HeartRhythm Case Rep"}],"container-title":["Journal of Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-020-00773-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13181-020-00773-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-020-00773-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T03:50:03Z","timestamp":1618458603000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13181-020-00773-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,15]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["773"],"URL":"https:\/\/doi.org\/10.1007\/s13181-020-00773-9","relation":{},"ISSN":["1556-9039","1937-6995"],"issn-type":[{"value":"1556-9039","type":"print"},{"value":"1937-6995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,15]]},"assertion":[{"value":"26 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}